Together, let’s Be Lunacious and rewrite the story of global health.
Join the Mission to Transforming Vaccine Access
Join us in closing the vaccine gap across Nigeria and Africa. We're tackling malaria, tuberculosis (TB), pneumococcal disease, Haemophilus influenzae type b (Hib), HPV, rotavirus, yellow fever, polio, measles, hepatitis B, and DTP (diphtheria, tetanus, and pertussis). Through local innovation and delivery, we welcome scientists, public health leaders, advocates, and bold thinkers to be part of the mission. Explore how you can get involved.
Vaccine Patches: Painless, Powerful, Needle-Free
We're is introducing microneedle patches (MAPs), a painless, needle-free way to deliver vaccines in underserved areas. Our pilot focuses on measles, with plans to expand into malaria and other high-burden diseases. We’re also tracking MAPs for TB and HPV as part of our long-term pipeline. These patches support drone and mobile van delivery systems, making immunization safer, simpler, and more accessible across Africa. Learn more about microneedle patches from Gavi.
Partnerships
LunaVax is on a mission to establish local vaccine production and strengthen immunization programs in Nigeria and Africa. We seek partners, funding, and collaborators from global health organizations to research institutions, governments, and private sector investors to bridge the gap, drive innovation, and save lives.
Explore ways to partner with us.
Innovative Vaccine Delivery: Smart Vans & Drones
LunaVax brings vaccines directly to hard-to-reach communities through mobile clinics and drone delivery. Our vans provide on-the-spot immunization, while drones navigate difficult terrain to ensure fast, temperature-stable supply. Together, they expand access where it's needed most. Learn more about our delivery systems.
Our Vaccine Technologies
We harness cutting-edge platforms including mRNA, self-amplifying RNA (saRNA), protein subunit, viral vector, and DNA-based vaccines to develop safe, scalable solutions for Africa’s most pressing vaccine-preventable diseases. These platforms support Nigeria’s immunization priorities while driving innovation for measles, TB, yellow fever, and rotavirus, where traditional methods still dominate. Explore our vaccine platforms.
Biometrics: Smarter Access to Immunization
LunaVax is integrating biometric tools, like fingerprint recognition and digital identity verification into our vaccine programs to ensure equitable access and accurate tracking. This innovation helps us reach individuals without formal IDs, reduce missed doses, and improve vaccine delivery in regions with limited health records. See how biometrics boost vaccine access.
Piloting microneedle patches and mobile vans in Nigeria — starting with measles. Learn how we’re reimagining vaccine delivery in hard-to-reach areas.—read the full article.
Stay updated on our latest breakthroughs! Explore our latest insights on vaccine innovation, partnerships, and funding.